CCR5 and HIV infectious disease: Thus, the observed reduction in CCR5 expression and inhibition of HIV infection with EGS C1 is primarily attributed to the targeted cleavage by RNase P as opposed to the antisense effect or other nonspecific effects of the EGSs.